Figure 4
Figure 4. SLPI is essential for granulocytic differentiation in vitro. CD34+ BM cells were transduced with lentiviral constructs of 2 different SLPI-specific RFP-tagged shRNAs (SLPI shRNA 1 and SLPI shRNA 2) or with irrelevant shRNA (ctrl shRNA). On day 4 of culture, RFP+ cells were sorted and in vitro granulocytic differentiation was tested. (A) β-Actin-normalized SLPI mRNA expression, in arbitrary units (AUs), in sorted RFP+ NB4 cells transduced with shRNA constructs as indicated above was measured by qRT-PCR; data represent mean ± SD of triplicates (*P < .05 vs control lv samples). (B) Representative western blot images showing SLPI protein expression in total lysates from RFP+ cells transduced with shRNA constructs as indicated above. Ponceau staining is depicted as a loading control. (C-D) Granulocytic differentiation of transduced CD34+ cells was tested using a liquid culture method. The percentage of CD11b+, CD15+, and CD16+ cells in the RFP+ cell population on day 14 of culture is presented. Data represent mean ± SD of triplicates of the median of 2 different SLPI shRNAs (SLPI shRNA1 and SLPI shRNA2) (*P < .05). (E-F) CD34+ BM cells, transduced with SLPI-specific or control-GFP–tagged shRNA constructs, were labeled with BrdU for 30 minutes, after which the percentage of BrdU+ cells (E) and cell-cycle profile (F) were assessed using a BrdU Flow Kit and FACS analysis, respectively. Data represent the median of 2 different samples of cells transduced with either SLPI-specific shRNA 1 or shRNA 2 (mean ± SD of triplicates of 3 experiments; *P < .05). (G) The apoptosis of CD34+ BM cells, transduced with SLPI-specific or control-GFP–tagged shRNA, was quantified by flow cytometry using an annexin V apoptosis detection kit. Data are expressed as the percentage of annexin V+ cells in the GFP+ cell population. Data represent the median of 2 different samples of cells transduced with either SLPI-specific shRNA 1 or shRNA 2 (mean ± SD of triplicates of 3 experiments; *P < .05). (H) CD34+ cells from healthy individuals (n = 3) were transduced with SLPI-specific or control-GFP–tagged shRNA lentiviral constructs, and GFP+ cells were sorted on day 4 of culture. The indicated CFU assays were performed. Data are mean ± SD and are derived from 2 independent experiments, each in duplicate (**P < .01).

SLPI is essential for granulocytic differentiation in vitro. CD34+ BM cells were transduced with lentiviral constructs of 2 different SLPI-specific RFP-tagged shRNAs (SLPI shRNA 1 and SLPI shRNA 2) or with irrelevant shRNA (ctrl shRNA). On day 4 of culture, RFP+ cells were sorted and in vitro granulocytic differentiation was tested. (A) β-Actin-normalized SLPI mRNA expression, in arbitrary units (AUs), in sorted RFP+ NB4 cells transduced with shRNA constructs as indicated above was measured by qRT-PCR; data represent mean ± SD of triplicates (*P < .05 vs control lv samples). (B) Representative western blot images showing SLPI protein expression in total lysates from RFP+ cells transduced with shRNA constructs as indicated above. Ponceau staining is depicted as a loading control. (C-D) Granulocytic differentiation of transduced CD34+ cells was tested using a liquid culture method. The percentage of CD11b+, CD15+, and CD16+ cells in the RFP+ cell population on day 14 of culture is presented. Data represent mean ± SD of triplicates of the median of 2 different SLPI shRNAs (SLPI shRNA1 and SLPI shRNA2) (*P < .05). (E-F) CD34+ BM cells, transduced with SLPI-specific or control-GFP–tagged shRNA constructs, were labeled with BrdU for 30 minutes, after which the percentage of BrdU+ cells (E) and cell-cycle profile (F) were assessed using a BrdU Flow Kit and FACS analysis, respectively. Data represent the median of 2 different samples of cells transduced with either SLPI-specific shRNA 1 or shRNA 2 (mean ± SD of triplicates of 3 experiments; *P < .05). (G) The apoptosis of CD34+ BM cells, transduced with SLPI-specific or control-GFP–tagged shRNA, was quantified by flow cytometry using an annexin V apoptosis detection kit. Data are expressed as the percentage of annexin V+ cells in the GFP+ cell population. Data represent the median of 2 different samples of cells transduced with either SLPI-specific shRNA 1 or shRNA 2 (mean ± SD of triplicates of 3 experiments; *P < .05). (H) CD34+ cells from healthy individuals (n = 3) were transduced with SLPI-specific or control-GFP–tagged shRNA lentiviral constructs, and GFP+ cells were sorted on day 4 of culture. The indicated CFU assays were performed. Data are mean ± SD and are derived from 2 independent experiments, each in duplicate (**P < .01).

Close Modal

or Create an Account

Close Modal
Close Modal